Few studies examine how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests assist or hinder efforts to prevent illness, hospitalisations, or people dying. Due to weak evidence, we’re ...
UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...
Children who experience Covid reinfection are twice as likely to develop long-term symptoms, including fatigue, heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback